Log in to save to my catalogue

Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury

Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5704279

Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury

About this item

Full title

Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury

Publisher

Greece: D.A. Spandidos

Journal title

Experimental and therapeutic medicine, 2017-11, Vol.14 (5), p.5017-5021

Language

English

Formats

Publication information

Publisher

Greece: D.A. Spandidos

More information

Scope and Contents

Contents

The present study investigated the clinical significance of the novel biomarker neutrophil gelatinase-associated lipocalin (NGAL) for the early diagnosis of acute renal injury (AKI). Thirty-eight critically ill patients with acute renal injury treated at Zhengzhou No. 7 People's Hospital between December 2015 and November 2016 served as the AKI gro...

Alternative Titles

Full title

Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5704279

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5704279

Other Identifiers

ISSN

1792-0981

E-ISSN

1792-1015

DOI

10.3892/etm.2017.5150

How to access this item